Century Therapeutics

Innovative biotechnology company focused on developing allogeneic induced pluripotent stem cell (iPSC)-derived cell therapies. Century Therapeutics leverages advanced gene editing, protein engineering, and manufacturing technologies to create iPSC-derived natural killer (NK) and T cell therapies, aiming to provide off-the-shelf solutions for cancer treatment. The primary beneficiaries of Century Therapeutics' innovations are patients with cancer, as well as healthcare providers seeking advanced therapeutic options.